Sequential analysis of SB cis vector-mediated gene expression in human T cells as related to DNA amounts used for nucleofection
. | pT2/DsRed . | . | pT2/DsRed/-SB10 . | . | . | ||
|---|---|---|---|---|---|---|---|
| Dose, by day . | Geometric mean (n = 10) . | 95% Cl . | Geometric mean (n = 10) . | 95% Cl . | P . | ||
| Day 21 | |||||||
| 10 μg | 0.58 | 0.28, 1.20 | 3.33 | 1.63, 6.80 | < .001 | ||
| 5 μg | 0.22 | 0.11, 0.44 | 1.62 | 0.79, 3.30 | < .001 | ||
| Day 28 | |||||||
| 10 μg | 0.20 | 0.11, 0.36 | 3.17 | 1.74, 5.80 | < .001 | ||
| 5 μg | 0.06 | 0.03, 0.11 | 1.26 | 0.69, 2.30 | < .001 | ||
. | pT2/DsRed . | . | pT2/DsRed/-SB10 . | . | . | ||
|---|---|---|---|---|---|---|---|
| Dose, by day . | Geometric mean (n = 10) . | 95% Cl . | Geometric mean (n = 10) . | 95% Cl . | P . | ||
| Day 21 | |||||||
| 10 μg | 0.58 | 0.28, 1.20 | 3.33 | 1.63, 6.80 | < .001 | ||
| 5 μg | 0.22 | 0.11, 0.44 | 1.62 | 0.79, 3.30 | < .001 | ||
| Day 28 | |||||||
| 10 μg | 0.20 | 0.11, 0.36 | 3.17 | 1.74, 5.80 | < .001 | ||
| 5 μg | 0.06 | 0.03, 0.11 | 1.26 | 0.69, 2.30 | < .001 | ||
Cl indicates confidence intervals.